Psoriatic arthritis and nail changes: Exploring the relationship

https://doi.org/10.1016/j.semarthrit.2014.05.002Get rights and content

Abstract

Objective

Psoriatic arthritis (PsA) has a diverse range of clinical manifestations, both articular and extra-articular. Although the association of PsA with skin changes is well established, the relationship of PsA with psoriatic nail changes remains relatively unexplored.

Methods

This report reviews the current literature surrounding the association of PsA with nail changes. A review of the literature was completed using PubMed, MEDLINE, and EMBASE in September 2013, encompassing years 1964–2012.

Results

A total of 21 articles were reviewed. On average, 66% [standard deviation (SD) 17.7] of PsA patients had nail changes. The type of nail changes and their associations varied widely between studies.

Conclusions

Studies of nail changes in PsA are highly variable with a wide range of results. Given the variability of results that were observed in this review, our recommendations are that further large studies on nail changes in patients with PsA should be conducted.

Introduction

Psoriatic arthritis (PsA) is a seronegative spondyloarthritis associated with disease of the axial and peripheral joints, affecting upwards of 0.2% of the general population and 16% of the population living with psoriasis [1], [2], [3], [4]. Clinical manifestations differ significantly between patients, with variations including joint, spine, and entheseal involvement, dactylitis, and new bone formation [3]. Extra-articular manifestations can also vary and may include cutaneous psoriasis, psoriatic nail changes, inflammatory bowel disease, and uveitis, with the cutaneous changes typically preceding the arthritis [5], [6]. The great diversity in the presentation and progression of PsA adds to the challenge of its diagnosis.

Although skin changes are associated with PsA, psoriasis and PsA appear to have different inheritance patterns, with PsA having a stronger hereditary link than psoriasis itself [7], [8]. Furthermore, human leukocyte antigen (HLA) typing seems to vary between the subtypes of PsA as well as between those PsA patients who progress differently along the disease course than others [9]. Multiple cytokines have been found in higher amounts than usual within the synovial tissue of PsA-affected joints, giving rise to the idea that multiple factors give rise to the joint damage associated with this disease [10], [11], [12], [13]. Receptor activator of nuclear factor kappa-B ligand (RANKL), a member of the tumor necrosis factor family, and interleukins 12 and 17 are three of the aforementioned cytokines that appear to be upregulated in PsA synovium [10], [11], [12], [13]. Along with a downregulation of RANKLs opposing cytokine receptor, osteoprotegerin, these alterations have been shown to contribute to the increased bone resorption and disease in PsA [10], [11], [12], [13].

To address the high variability of PsA, the current classification criteria, the ClASsification criteria for Psoriatic Arthritis (CASPAR) criteria (Table 1), include a combination of articular and extra-articular findings, along with personal and family history [3]. Although primarily including patients who had long-standing PsA (mean activity of 12.5 years), the original CASPAR study on this topic showed a high specificity and sensitivity (98.7% and 91.4%, respectively) [3]. A high sensitivity was later confirmed in early PsA patients [14]. However, it was noted that although the CASPAR criteria has good applicability in specialty rheumatology clinics, the ill-defined nature of inflammatory arthritis with regard to joint, spine, or entheseal disease may be problematic outside of these specialized clinics [14].

One of the CASPAR criteria, new bone formation in the juxtaarticular region on radiography, has lead researchers to look into new ways to discover such changes [3]. Recently, magnetic resonance imaging (MRI) and ultrasound imaging have become helpful tools in imaging the bone changes associated with PsA [15], [16], [17], [18], [19], [20], [21], [22], [23]. These imaging modalities may offer an explanation for why nail changes are associated with PsA. The use of new imaging techniques has led to the proposition that nail changes represent an enthesitis of the nail bed and matrix due to an association that exists between these structures and the nearby tendons and ligaments [16], [17], [18], [19], [20], [21], [22], [23], [24].

PsA nail changes are typically divided into those involving the nail matrix vs. those involving the nail bed [25]. When nail matrix disease is present, the typical findings include pitting, leukonychia, nail plate crumbling, red spots on the lunula, and onychorrhexis (Fig. 1). This is in contrast to oil spot changes, onycholysis, subungual hyperkeratosis, and splinter hemorrhages, which are signs of nail bed disease (Fig. 2) [26], [27], [28].

Each of the different nail changes arise from unique processes within the nail complex. The loss of abnormal keratinocytes situated on the nail plate as it grows past the cuticle leaves divots or pits in its place [26], [28], [29]. Leukonychia are white discolorations in the nail plate from inflammation in the middle portion of the nail matrix [29]. With a high degree of inflammation in the nail matrix, nail plate disfiguration or crumbling occurs [28]. Nail ridging (onychorrhexis) can correspond with linear inflammation within the nail matrix [26], [29]. Red spots on the lunula are thought to be a consequence of increase blood flow to the nail matrix [30]. Oil spot changes are simply from an increased concentration of dead or damaged cells, as well as proteinaceous fluid [26], [28], [31]. Inflammation occurring at the tip of the nail causes a detachment of the nail plate and the corresponding lifted appearance of the nail [29]. Subungual hyperkeratosis is caused by increased keratinization on the nail bed, producing a thickening of the nail bed itself [26], [29]. As the nail grows out, fragile blood vessels of the nail bed can be irritated, causing blood to extravasate, resulting in red or purple linear discolorations or splinter hemorrhages [28], [29].

The subtypes that are noted to be associated with PsA in the literature vary from study to study. In fact, even the overall number of patients with PsA who have nail changes appears to fluctuate greatly from study to study, ranging from those values less than 40% to those greater than 80% [26], [32], [33], [34], [35], [36], [37]. This review serves to consolidate the literature regarding nail findings in PsA patients.

Section snippets

Material and methods

A review of the literature was completed using PubMed, MEDLINE, and EMBASE in September 2013, encompassing years 1964–2012, in order to determine the current research on the significance of nail changes with PsA. To do this, we searched for the terms “psoriatic arthritis” AND “nail” in titles and abstracts. The articles were reviewed for those that discussed the relationship between nail changes and PsA, and 21 articles were found (Fig. 3). All articles were included regardless of study design

Results

Among the 21 articles that were used for this review, a large range of variation was found for the percentage of PsA patients who have nail changes: the lowest being 32% and the highest being 97% (Table 2). On average, 66% [standard deviation (SD) 17.7] of PsA patients had nail changes. The Cassell 2007 article was excluded from this calculation as we were unable to calculate such a percentage from their data (Table 3). The oldest two articles reviewed, from 1964 to 1979, had found 83% [38] and

Discussion

The theory that the entheses in proximity of the nail bed and the nail matrix are actually anatomically related has been highlighted in a number of studies [20], [22], [27], [55]. Researchers have put forth the idea that the nail changes, and even some of the skin changes associated with PsA, may actually originate from a Koebner response to the underlying joint disease [20], [22], [24], [27], [55]. A study that used MRI imaging in PsA patients demonstrated the close relationship of the nail

Conclusion

Given the variability of results that were observed in this review, our recommendations are that further large studies on nail changes in patients with PsA should be conducted using the CASPAR criteria as the method of recruitment so as to not restrict participation to those with just skin changes. Evaluating the subtypes of psoriatic nail changes could also be helpful to further show if any one subtype, or even a category of subtypes (nail matrix vs. nail bed changes), is more or less

Acknowledgment

We thank Dr. Lyn Guenther for her kind assistance in the analysis of nail photographs.

References (59)

  • M. Dougados et al.

    The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy

    Arthritis Rheum

    (1991)
  • V. Chandran et al.

    Familial aggregation of psoriatic arthritis

    Ann Rheum Dis

    (2009)
  • D.D. O′Rielly et al.

    Genetics of susceptibility and treatment response in psoriatic arthritis

    Nat Rev Rheumatol

    (2011)
  • C.T. Ritchlin et al.

    Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis

    J Clin Invest

    (2003)
  • C. Ryan et al.

    Current investigational drugs in psoriasis

    Expert Opin Investig Drugs

    (2012)
  • A.W. van Kuijk et al.

    Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment

    Ann Rheum Dis

    (2006)
  • T. Yago et al.

    IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats

    Arthritis Res Ther

    (2007)
  • V. Chandran et al.

    Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis

    Arthritis Rheum

    (2007)
  • N. Dalbeth et al.

    Nail disease in psoriatic arthritis: distal phalangeal bone edema detected by magnetic resonance imaging predicts development of onycholysis and hyperkeratosis

    J Rheumatol

    (2012)
  • E. de Miguel et al.

    Validity of enthesis ultrasound assessment in spondyloarthropathy

    Ann Rheum Dis

    (2009)
  • E. Filippucci et al.

    Reliability of high-resolution ultrasonography in the assessment of Achilles tendon enthesopathy in seronegative spondyloarthropathies

    Ann Rheum Dis

    (2009)
  • R. Scarpa et al.

    Is the involvement of the distal interphalangeal joint in psoriatic patients related to nail psoriasis?

    Clin Rheumatol

    (2004)
  • R. Scarpa et al.

    Nail and distal interphalangeal joint in psoriatic arthritis

    J Rheumatol

    (2006)
  • A.L. Tan et al.

    What imaging has told us about psoriatic arthritis

    Rheumatol Pract

    (2007)
  • A.L. Tan et al.

    The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis—a high-resolution MRI and histological study

    Rheumatology (Oxford)

    (2007)
  • A.L. Tan et al.

    A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: are they the same?

    Arthritis Rheum

    (2006)
  • D. McGonagle et al.

    The biomechanical link between skin and joint disease in psoriasis and psoriatic arthritis: what every dermatologist needs to know

    Ann Rheum Dis

    (2008)
  • D. de Berker

    Management of psoriatic nail disease

    Semin Cutan Med Surg

    (2009)
  • D. McGonagle

    Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease

    J Eur Acad Dermatol Venereol

    (2009)
  • Cited by (32)

    • A standardized sonographic analysis of nails in psoriatic arthritis and healthy controls: Feasibility, reliability, diagnostic performance, and demographic and clinical associations

      2021, Joint Bone Spine
      Citation Excerpt :

      In addition, assessments were made on a wide range of nails and using the results of both nail-based and individual-based trials of many sizes. It is important to include almost all findings because onychopathy increases the risk of developing PsA increases in psoriasis [5,24,25]. The first finger- and toenails exhibited good diagnostic performances in terms of NPI, the rarely used fingernails in terms of NT and NBT, and the nondominant hand nails in terms of DA.

    • Detection of subclinical ultrasound enthesopathy and nail disease in patients at risk of psoriatic arthritis

      2017, Joint Bone Spine
      Citation Excerpt :

      Love et al. have showed that onycholysis was associated with psoriatic arthritis [11] while Maejima et al., have suggested an association with onycholysis and nail bed hyperkeratosis [12]. However, in a recent review of the relationship between psoriatic arthritis and nail changes, Sandre et al. have found that associations varied widely and that further large studies on nail changes were needed [13]. Nail is now recognized to be integrated with the entheses [14–17].

    • Impact of training on concordance among rheumatologists and dermatologists in the assessment of patients with psoriasis and psoriatic arthritis

      2016, Seminars in Arthritis and Rheumatism
      Citation Excerpt :

      The most commonly used measures for assessing the severity of skin psoriasis include the Psoriasis Area and Severity Index (PASI) and the physician’s global assessment (PGA) [7,10], which is considered subjective but more closely reflects assessment in clinical practice [11], and the body surface area (BSA) [7], which may show some interrater reliability [12–14]. Nail lesions occurs in as many as 50% [15] of patients with psoriasis and in about 65% of patients with PsA [16], and is most commonly measured by using the Nail Psoriasis Severity Index (NAPSI) [17]. The assessment of joints involves counting the number of tender and swollen joints [5,6].

    View all citing articles on Scopus
    View full text